Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:24852901 | ||||
pmid:24850753 | ||||
pmid:29485004 | ||||
pmid: | ||||
Kagan L et al. | Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data. | 2011 | AAPS J | pmid:21431453 |
Baas B et al. | Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form. | 1999 | AAPS PharmSci | pmid:11741206 |
Darole PS et al. | Formulation and evaluation of microemulsion based delivery system for amphotericin B. | 2008 | AAPS PharmSciTech | pmid:18446472 |
Kaur L et al. | A Mechanistic Study to Determine the Structural Similarities Between Artificial Membrane Strat-Mâ„¢ and Biological Membranes and Its Application to Carry Out Skin Permeation Study of Amphotericin B Nanoformulations. | 2018 | AAPS PharmSciTech | pmid:29488196 |
Adhikari K et al. | Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation. | 2016 | AAPS PharmSciTech | pmid:26349688 |
Patere SN et al. | Surface-Modified Liposomal Formulation of Amphotericin B: In vitro Evaluation of Potential Against Visceral Leishmaniasis. | 2017 | AAPS PharmSciTech | pmid:27222025 |